Ceres, a Thousand Oaks based agriculture-biotechnology company, saw shares spike 373 percent Wednesday after the company received a patent for its iCODE multi-gene trait development system. Ceres shares started the day at just 95 cents per share, and soared all the way to $4.80 when the markets opened at 6:30 a.m. PST. Ceres closed the Read More →
Sitting in public-company-listing limbo with a listing deadline on its current stock price, Thousand Oaks-based energy crop producer Ceres will attempt to continue its numerous pricey research projects by balancing them with new revenue streams.
Shares of Thousand Oaks-based energy crop firm Ceres were up 8 percent in midday trading on news that the company inked a deal to monetize its genome viewing software through a deal with Bayer CropScience.
Thousand Oaks-based energy crop firm Ceres has been granted a patent on a gene sequence derived from corn and plans to license the patent to big seed companies.
Thousand Oaks-based energy crop company Ceres could be booted from the Nasdaq stock exchange if it doesn’t get its share price back above $1 in the next six months. Ceres said that it received a letter from the Nasdaq on April 28 notifying it that because its share price has lingered below $1 for 30 Read More →
Thousand Oaks-based energy crop firm Ceres has raised $23 million that it hopes will help it to break even as it continues testing its seeds in Brazil.
The Thousand Oaks-based firm said it would like to use the proceeds from the public offering to expand its Brazilian operations, participate in collaborations and break into new markets.